Skip to NavigationSkip to content

News

The FDA has approved the first three generic versions of Novartis’ sphingosine 1-phosphate receptor modulator Gilenya (fingolimod) to treat adult...
NDA's Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising...
Novartis is teaming up with Amazon Web Services to utilise its cloud computing technology. The collaboration is designed to overhaul Novartis’s...
A person has been diagnosed with the rare viral infection monkeypox in South West England. It is believed they contracted it while staying in...
The number of illegal diazepam tablets seized by the UK Border Force has doubled in a year, going from 545,000 in 2017 to 1.3 million in 2018.
A team of biomedical scientists at the University of California has found that a FDA-approved drug for treating rheumatoid arthritis and ulcerative...
New Phase 3 data has been released showing that both 50mg and 100mg doses of Allergan’s ubrogepant met their primary endpoints in the acute...
Dr Stephen Hahn, President Donald Trump’s FDA nominee, has advanced his nomination to the full Senate chamber.
A drug for male birth control may hold promise for treating lung cancer patients when treatments like immunotherapy do not work.
Johnson & Johnson has secured approval from the FDA for its Tecnis Toris II 1-Piece Intraocular Lens (IOL).
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches